Eton Pharmaceuticals appoints James Gruber as CFO; Wilson Troutman retires

Eton Pharmaceuticals, Inc.

James Gruber appointed CFO, Treasurer, Secretary effective April 11, 2022.
Gruber previously U.S. Controller at Horizon Therapeutics for 7 years.
Wilson Troutman retired as CFO, will assist transition through May 31, 2022.
Gruber receives $350K base salary, 40% target bonus, option for 100,000 shares vesting over 4 years.
Company owns or receives royalties from six FDA-approved products, four more submitted.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Wilson Troutman

Chief Financial Officer, Corporate Secretary and Treasurer

ETON · Eton Pharmaceuticals, Inc.

Effective: 2022-04-11
Successor: James Gruber
Filed: April 11, 2022, 7:59 PM ET

Mr. Gruber succeeds Wilson Troutman, who retired as Chief Financial Officer, Corporate Secretary and Treasurer of the Company effective April 11, 2022 as well.

Appointed

James Gruber

Chief Financial Officer, Corporate Secretary and Treasurer

ETON · Eton Pharmaceuticals, Inc.

Effective: 2022-04-11
Filed: April 11, 2022, 7:59 PM ET

Effective April 11, 2022 the Board of Directors (the “Board”) of Eton Pharmaceuticals, Inc. (the “Company”) appointed James Gruber to serve as the Company’s Chief Financial Officer, Corporate Secretary and Treasurer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wilson Troutman retired as Chief Financial Officer, Corporate Secretary and Treasurer at Eton Pharmaceuticals, Inc..

Action: retired
Role: Chief Financial Officer, Corporate Secretary and Treasurer

Exact text from the filing

Mr. Gruber succeeds Wilson Troutman, who retired as Chief Financial Officer, Corporate Secretary and Treasurer of the Company effective April 11, 2022 as well.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

James Gruber was appointed as Chief Financial Officer, Corporate Secretary and Treasurer at Eton Pharmaceuticals, Inc..

Action: appointed
Role: Chief Financial Officer, Corporate Secretary and Treasurer

Exact text from the filing

Effective April 11, 2022 the Board of Directors (the “Board”) of Eton Pharmaceuticals, Inc. (the “Company”) appointed James Gruber to serve as the Company’s Chief Financial Officer, Corporate Secretary and Treasurer.

View on SEC.gov

Eton Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-009587

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.